Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid during anterior cruciate ligament reconstruction
IRCT20201015049033N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in anterior cruciate ligament injury comparing Tranexamic acid with Placebo normal saline (2 arms). Primary endpoints: Joint pain, Range of motion of the joint and 4 more. Started Sep 2021; status: completed.
02
Drugs
tranexamic acid
03
Conditions
anterior cruciate ligament injury
Beyond the preview
Go deeper on IRCT20201015049033N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201015049033N1.